CISPLATIN PLUS VP16-213 IN ADVANCED OVARIAN-CARCINOMA

被引：4
作者：
HARNETT, PR
BELL, DR
HILLCOAT, BL
WOODS, RL
LEVI, JA
ROME, RM
CAMPBELL, JC
TATTERSALL, MHN
机构：
[1] ROYAL WOMENS HOSP,ONCOL UNIT,MELBOURNE,VIC 3000,AUSTRALIA
[2] ROYAL N SHORE HOSP,DEPT CLIN ONCOL,ST LEONARDS,NSW 2065,AUSTRALIA
[3] CANC INST,DEPT CANC MED,MELBOURNE,VIC 3000,AUSTRALIA
[4] PETER MACCALLUM HOSP,MELBOURNE,VIC 3000,AUSTRALIA
来源：
GYNECOLOGIC ONCOLOGY | 1988年 / 30卷 / 02期
关键词：
D O I：
10.1016/0090-8258(88)90019-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：159 / 162
页数：4
相关论文
共 50 条
  • [21] VP16-213 AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
    ESTAPE, J
    CIRERA, L
    MILLA, A
    DONCEL, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (03) : 154 - 157
  • [22] THE PODOPHYLLOTOXIN DERIVATIVES VP16-213 AND VM26
    ISSELL, BF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 73 - 80
  • [23] MONOAGENT VP16-213 IN BRONCHOGENIC-CARCINOMA AND REPORT OF TOXICITY IN COMBINATION WITH OTHER CYTOTOXICS
    ANDERSON, G
    PEEL, ET
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 239 - 239
  • [24] RANDOMIZED COMPARISON OF CISPLATIN PLUS EPIRUBICIN OR DOXORUBICIN FOR ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A MULTICENTER TRIAL
    HOMESLEY, HD
    HARRY, DS
    OTOOLE, RV
    HOOGSTRATEN, B
    FRANKLIN, EW
    CAVANAGH, D
    NAHHAS, WA
    SMITH, JJ
    LOVELACE, JV
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (02): : 129 - 134
  • [25] NEPHROTIC SYNDROME AFTER CISPLATIN PLUS CYCLOPHOSPHAMIDE FOR OVARIAN-CARCINOMA
    BERETTA, R
    CATTANEO, MT
    DAMIANI, E
    LUCHINI, S
    ZUCCA, E
    TRABATTONI, A
    NATALE, N
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 543 - 544
  • [26] 鬼臼毒素衍生物VP16-213
    张覃沐
    国外医学药学分册., 1980, (04) : 251 - 252
  • [27] VP16-213 PHASE-II STUDY SMALL CELL LUNG-CARCINOMA
    LARRIBA, JLG
    CARCIA, JMM
    GALLEGO, AO
    ALONSO, SJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 239 - 240
  • [28] PHASE-II STUDY OF VP16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA
    SCHELL, FC
    YAP, HY
    HORTOBAGYI, GN
    ISSELL, B
    ESPARZA, L
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 223 - 225
  • [29] IMMUNOCYTOCHEMICAL LOCALIZATION OF VP16-213 IN NORMAL AND MALIGNANT-TISSUES
    HENNEBERRY, HP
    AHERNE, GW
    MARKS, V
    CANCER LETTERS, 1987, 37 (02) : 225 - 233
  • [30] CLINICAL-PHARMACOLOGY OF HIGH-DOSE VP16-213
    HANDE, KR
    MCKAY, CM
    WEDLUND, PJ
    NOONE, RM
    SHEA, WK
    FER, MF
    GRECO, FA
    WOLFF, SN
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 131 - 131
12345